Medical Frontiers
While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30 per cent of patients - we interview Japanese researchers trying to overcome this challenge.
Rai 1 - 20:35
Rai 2 - 21:00
Rai 3 - 21:20